ACTION DE LA BUNAFTINE SUR LA PHASE SUPERNORMALE DE L'EXCITABILITE MYOCARDIQUE

Translated title of the contribution: Investigation of the action of Bunaftine on the supranormal phase of myocardial excitability

G. Critelli, F. Rengo, L. Adinolfi, V. Santinelli, G. Ferro, F. Perticone, M. Condorelli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In 8 patients with a temporary pacemaker, investigations were carried out into the supranormal phase of excitability induced by Bunaftine, a derivative of ethylenediamine, which has anti-arrhythmic properties. During continuous electrocardiographic recording, and after assessment of the threshold of myocardial stimulation, the supranormal phase was shown by the occasional depolarising effect of subliminal stimulation. By examining the chronological relationship between effective subliminal stimulation and spontaneous rhythm complexes, it was possible to calculate the beginning, end and the duration of the supranormal phase. The Q-T interval, the QRS interval and cardiac frequency were also calculated. The most important factor in this investigation was the decrease, by an average of 57.3 % of the duration of the supranormal phase (p <0.001) after Bunaftine treatment. At the same time, there was found to be a lengthening of the Q-T interval by 11.8 % (p <0,001). The drug does not cause any significant changes in either the length of the QRS interval or cardiac frequency. It is therefore possible that the effect of Bunaftine on the supranormal phase is one way in which it exercises its antiarrhythmic effect.

Original languageFrench
Pages (from-to)141-147
Number of pages7
JournalAnnales de Cardiologie et d'Angeiologie
Volume26
Issue number2
Publication statusPublished - 1977

Fingerprint

Bunaftine
Subliminal Stimulation
ethylenediamine
Anti-Arrhythmia Agents
Exercise
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Critelli, G., Rengo, F., Adinolfi, L., Santinelli, V., Ferro, G., Perticone, F., & Condorelli, M. (1977). ACTION DE LA BUNAFTINE SUR LA PHASE SUPERNORMALE DE L'EXCITABILITE MYOCARDIQUE. Annales de Cardiologie et d'Angeiologie, 26(2), 141-147.

ACTION DE LA BUNAFTINE SUR LA PHASE SUPERNORMALE DE L'EXCITABILITE MYOCARDIQUE. / Critelli, G.; Rengo, F.; Adinolfi, L.; Santinelli, V.; Ferro, G.; Perticone, F.; Condorelli, M.

In: Annales de Cardiologie et d'Angeiologie, Vol. 26, No. 2, 1977, p. 141-147.

Research output: Contribution to journalArticle

Critelli, G, Rengo, F, Adinolfi, L, Santinelli, V, Ferro, G, Perticone, F & Condorelli, M 1977, 'ACTION DE LA BUNAFTINE SUR LA PHASE SUPERNORMALE DE L'EXCITABILITE MYOCARDIQUE', Annales de Cardiologie et d'Angeiologie, vol. 26, no. 2, pp. 141-147.
Critelli, G. ; Rengo, F. ; Adinolfi, L. ; Santinelli, V. ; Ferro, G. ; Perticone, F. ; Condorelli, M. / ACTION DE LA BUNAFTINE SUR LA PHASE SUPERNORMALE DE L'EXCITABILITE MYOCARDIQUE. In: Annales de Cardiologie et d'Angeiologie. 1977 ; Vol. 26, No. 2. pp. 141-147.
@article{ce45408da180470586177cebf730031b,
title = "ACTION DE LA BUNAFTINE SUR LA PHASE SUPERNORMALE DE L'EXCITABILITE MYOCARDIQUE",
abstract = "In 8 patients with a temporary pacemaker, investigations were carried out into the supranormal phase of excitability induced by Bunaftine, a derivative of ethylenediamine, which has anti-arrhythmic properties. During continuous electrocardiographic recording, and after assessment of the threshold of myocardial stimulation, the supranormal phase was shown by the occasional depolarising effect of subliminal stimulation. By examining the chronological relationship between effective subliminal stimulation and spontaneous rhythm complexes, it was possible to calculate the beginning, end and the duration of the supranormal phase. The Q-T interval, the QRS interval and cardiac frequency were also calculated. The most important factor in this investigation was the decrease, by an average of 57.3 {\%} of the duration of the supranormal phase (p <0.001) after Bunaftine treatment. At the same time, there was found to be a lengthening of the Q-T interval by 11.8 {\%} (p <0,001). The drug does not cause any significant changes in either the length of the QRS interval or cardiac frequency. It is therefore possible that the effect of Bunaftine on the supranormal phase is one way in which it exercises its antiarrhythmic effect.",
author = "G. Critelli and F. Rengo and L. Adinolfi and V. Santinelli and G. Ferro and F. Perticone and M. Condorelli",
year = "1977",
language = "Francese",
volume = "26",
pages = "141--147",
journal = "Annales de Cardiologie et d'Angeiologie",
issn = "0003-3928",
publisher = "Elsevier Masson",
number = "2",

}

TY - JOUR

T1 - ACTION DE LA BUNAFTINE SUR LA PHASE SUPERNORMALE DE L'EXCITABILITE MYOCARDIQUE

AU - Critelli, G.

AU - Rengo, F.

AU - Adinolfi, L.

AU - Santinelli, V.

AU - Ferro, G.

AU - Perticone, F.

AU - Condorelli, M.

PY - 1977

Y1 - 1977

N2 - In 8 patients with a temporary pacemaker, investigations were carried out into the supranormal phase of excitability induced by Bunaftine, a derivative of ethylenediamine, which has anti-arrhythmic properties. During continuous electrocardiographic recording, and after assessment of the threshold of myocardial stimulation, the supranormal phase was shown by the occasional depolarising effect of subliminal stimulation. By examining the chronological relationship between effective subliminal stimulation and spontaneous rhythm complexes, it was possible to calculate the beginning, end and the duration of the supranormal phase. The Q-T interval, the QRS interval and cardiac frequency were also calculated. The most important factor in this investigation was the decrease, by an average of 57.3 % of the duration of the supranormal phase (p <0.001) after Bunaftine treatment. At the same time, there was found to be a lengthening of the Q-T interval by 11.8 % (p <0,001). The drug does not cause any significant changes in either the length of the QRS interval or cardiac frequency. It is therefore possible that the effect of Bunaftine on the supranormal phase is one way in which it exercises its antiarrhythmic effect.

AB - In 8 patients with a temporary pacemaker, investigations were carried out into the supranormal phase of excitability induced by Bunaftine, a derivative of ethylenediamine, which has anti-arrhythmic properties. During continuous electrocardiographic recording, and after assessment of the threshold of myocardial stimulation, the supranormal phase was shown by the occasional depolarising effect of subliminal stimulation. By examining the chronological relationship between effective subliminal stimulation and spontaneous rhythm complexes, it was possible to calculate the beginning, end and the duration of the supranormal phase. The Q-T interval, the QRS interval and cardiac frequency were also calculated. The most important factor in this investigation was the decrease, by an average of 57.3 % of the duration of the supranormal phase (p <0.001) after Bunaftine treatment. At the same time, there was found to be a lengthening of the Q-T interval by 11.8 % (p <0,001). The drug does not cause any significant changes in either the length of the QRS interval or cardiac frequency. It is therefore possible that the effect of Bunaftine on the supranormal phase is one way in which it exercises its antiarrhythmic effect.

UR - http://www.scopus.com/inward/record.url?scp=0017353548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017353548&partnerID=8YFLogxK

M3 - Articolo

VL - 26

SP - 141

EP - 147

JO - Annales de Cardiologie et d'Angeiologie

JF - Annales de Cardiologie et d'Angeiologie

SN - 0003-3928

IS - 2

ER -